ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 68 filers reported holding ONCOMED PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 30.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $507,000 | -27.4% | 219,420 | 0.0% | 0.00% | -50.0% |
| Q1 2018 | $698,000 | -22.4% | 219,420 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $900,000 | -9.3% | 219,420 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $992,000 | +35.7% | 219,420 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $731,000 | -50.2% | 219,420 | +37.6% | 0.00% | -50.0% |
| Q1 2017 | $1,468,000 | -17.3% | 159,420 | -30.8% | 0.00% | -20.0% |
| Q4 2016 | $1,776,000 | -32.5% | 230,400 | 0.0% | 0.01% | -28.6% |
| Q3 2016 | $2,633,000 | +176.6% | 230,400 | +197.8% | 0.01% | +250.0% |
| Q2 2016 | $952,000 | -49.0% | 77,370 | -58.0% | 0.00% | -60.0% |
| Q1 2016 | $1,865,000 | – | 184,430 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $16,944,000 | 4.17% |
| BVF INC/IL | 1,760,489 | $16,214,000 | 2.76% |
| Iguana Healthcare Management, LLC | 490,000 | $4,513,000 | 2.23% |
| Broadfin Capital, LLC | 300,000 | $2,763,000 | 0.34% |
| TURNER INVESTMENTS LLC | 38,083 | $351,000 | 0.23% |
| Birchview Capital, LP | 34,689 | $319,000 | 0.18% |
| Piermont Capital Management Inc. | 52,195 | $481,000 | 0.12% |
| Cannell & Co. | 331,296 | $3,051,000 | 0.11% |
| NJ State Employees Deferred Compensation Plan | 48,000 | $442,000 | 0.08% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 324,350 | $2,987,000 | 0.07% |